Yongfeng Yang

1.5k citations
33 papers · 427 indexed · h-index 11
Topics
Liver Disease Diagnosis and Treatment (17 papers)Hepatitis B Virus Studies (13 papers)Hepatitis C virus research (9 papers)
Partner nations
ChinaUnited States

In The Last Decade

Yongfeng Yang

24 papers receiving 420 citations

Peers

Yongfeng Yang
Comparison fields: 5 of 67
  • Epidemiology 267
  • Hepatology 244
  • Molecular Biology 105
  • Cancer Research 88
  • Infectious Diseases 30
Replace Doan Y Dao with:
Doan Y Dao United States
Rajneesh Kumar Singapore
Richard S. Hann United States
Guillaume Fallot France
Yang Jae Yoo South Korea
Natsuko Nakakuki Japan
Lubiao Chen China
Aline Lopes Chagas Brazil
Dirk Michels Germany
Luciana Kikuchi Brazil
Yongfeng Yang relative to Doan Y Dao United States Doan Y Dao's profile →
Citations per field
00.5×3.4×
Doan Y Dao · 1×
Citations per year

Countries citing papers authored by Yongfeng Yang

Since Specialization
Citations

This map shows the geographic impact of Yongfeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongfeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongfeng Yang more than expected).

Fields of papers citing papers by Yongfeng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongfeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongfeng Yang. The network helps show where Yongfeng Yang may publish in the future.

Co-authorship network of co-authors of Yongfeng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yongfeng Yang. A scholar is included among the top collaborators of Yongfeng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongfeng Yang. Yongfeng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 0
4 0
5 0
6 0
7 0
8 4
9 1
10 0
11 0
12 4
13 9
14 64
15
MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase.
48
16 23
17 10
18 17
19 28
20 14

About Yongfeng Yang

Yongfeng Yang is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 33 papers that have together received 427 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (17 papers), Hepatitis B Virus Studies (13 papers) and Hepatitis C virus research (9 papers). The work is most often cited by research in Hepatology (244 citations), Epidemiology (267 citations) and Cancer Research (88 citations). Yongfeng Yang has collaborated with scholars based in China and United States. Frequent co-authors include Wei Zhao, Huimin Xia, Lei Shen, Lili Ju, Xiaofeng Zheng, Zefang Tang, Yapeng Ji, Xi Zhu, Chuanzhen Yang and Hongwei Yao. Their work appears in journals such as Nature Communications, PLoS ONE and Frontiers in Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026